Large-scale testing (Phase 3)Study completedNCT02652780
What this trial is testing
Efficacy Study of GS010 for Treatment of Vision Loss From 7 Months to 1 Year From Onset in LHON Due to the ND4 Mutation (REVERSE)
Who this might be right for
Optic, Atrophy, Hereditary, Leber
GenSight Biologics 37